Quarterly report pursuant to Section 13 or 15(d)

Public Offering (Details)

v3.20.2
Public Offering (Details) - USD ($)
1 Months Ended 9 Months Ended
Sep. 17, 2020
Nov. 27, 2017
May 31, 2020
Oct. 31, 2019
Nov. 21, 2017
Sep. 30, 2020
Public Offering (Details) [Line Items]            
Deferred underwriting fee payable $ 4,500,000          
Redeemable common stock, shares     23,182,481 694,820   23,877,302
redeemed shares value     $ 242,423,000 $ 7,108,000   $ 249,531,000
Maximum [Member]            
Public Offering (Details) [Line Items]            
Deferred underwriting fee payable 10,500,000          
Minimum [Member]            
Public Offering (Details) [Line Items]            
Deferred underwriting fee payable $ 6,000,000          
IPO [Member]            
Public Offering (Details) [Line Items]            
Sale of stock         30,000,000  
Sale of stock per share         $ 10.00  
Initial business combination, description         Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value and one redeemable common stock purchase warrant (the “Warrants”). Under the terms of a warrant agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the initial business combination. Each Warrant entitles the holder to purchase one half of one share of Class A common stock at a price of $5.75 (11.50 per whole share). No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of shares of Class A common stock to be issued to the warrant holder.  
Shares subject to forfeiture   1,125,000        
Underwriting discount, description   The Company paid an underwriting discount of 2% of the per Unit offering price to the underwriters at the closing of the Public Offering ($6,000,000), with an additional fee (the “Deferred Discount”) of 3.5% of the gross offering proceeds ($10,500,000) payable upon the Company’s completion of a business combination.        
Over-Allotment Option [Member]            
Public Offering (Details) [Line Items]            
Sale of stock         4,500,000  
Warrant [Member] | IPO [Member]            
Public Offering (Details) [Line Items]            
Initial business combination, description           Each Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Public Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on or prior to the Extended Date allotted to complete the Business Combination, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of Warrants issued in connection with the 30,000,000 public units during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the warrants become exercisable, the Company may redeem the outstanding warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.